Life sciences have taken on increased importance in recent months, and are sure to be a significant part of Canada’s post-pandemic economy. Join us for our five-part webinar series that will discuss the latest legal and regulatory developments at all stages of the sector’s complex life cycle.

Product liability litigation remains a challenging, business-critical risk for pharmaceutical and medical device manufacturers. Join Grant Worden, Sylvie Rodrigue and Nicole Mantini as they examine current and emerging trends relating to “mass torts”, the management of complex, multi-jurisdictional proceedings and copycat litigation from other jurisdictions. The panel will also review recent notable decisions and changes to Ontario’s Class Proceedings Act, and will discuss emerging issues for 2021 and beyond.

9:00 a.m. EDT Webinar opens
9:15 - 10:15 a.m. EDT Presentation

Ontario: This program is eligible for up to 1.0 Substantive hour.
New York: This program contains 1.0 Areas of Professional Practice Credit.

Click here to register.

Sessions in this series:

• Navigating (and challenging) a changing life sciences regulatory environment
• Life sciences product liability litigation: managing risks and anticipating trends
• The latest developments in life sciences IP litigation
• Life sciences and centralized procurement: navigating the process and responding to RFPs
• Financing life sciences on both sides of the border